Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study will compare a single dose of oral solithromycin to the standard of care (intramuscular ceftriaxone plus oral azithromycin) in the treatment of patients with urogenital gonorrhea. A completed open-label Phase 2 study with single doses of solithromycin resulted in 100% microbiological eradication in male and female patients with uncomplicated urogenital gonorrhea.
Epistemonikos ID: 739d7df70cb9fbd5d2cebc9e56c6f3e1e0b41728
First added on: May 12, 2024